Health Care & Life Sciences » Pharmaceuticals | Celltrion Pharm Inc.

Celltrion Pharm Inc. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
3,622
5,869
6,734
2,916
2,877
Depreciation, Depletion & Amortization
1,050
1,187
1,466
12,413
16,858
Other Funds
1
-
3,000
32
5
Funds from Operations
6,691
1,597
10,303
19,165
21,360
Changes in Working Capital
79,068
5,600
18,679
36,256
31,045
Net Operating Cash Flow
72,377
7,197
8,376
17,091
9,684
Capital Expenditures
28,701
35,051
62,867
13,825
1,788
Sale of Fixed Assets & Businesses
-
124
1
18
-
Purchase/Sale of Investments
3,242
445
1,396
-
-
Net Investing Cash Flow
27,212
34,438
62,779
6,749
1,491
Issuance/Reduction of Debt, Net
105,727
19,156
55,312
23,455
5,644
Net Financing Cash Flow
105,726
19,156
60,527
24,322
6,646
Net Change in Cash
6,130
8,055
6,138
493
4,557
Free Cash Flow
96,853
18,961
34,425
19,176
10,764
Other Sources
6,685
167
21,466
7,228
852
Change in Capital Stock
-
-
2,215
898
1,008
Exchange Rate Effect
7
29
14
11
28
Other Uses
8,561
-
20,000
152
554

About Celltrion Pharm

View Profile
Address
82 2sandan-ro
Cheongju-si NC 28117
Korea, Republic Of
Employees -
Website http://www.celltrionph.com
Updated 09/14/2018
Celltrion Pharm, Inc. engages in the manufacture and sale of pharmaceuticals. Its products are categorized into the following: the group of medicine effect, biosimilars and over-the-counter (OTC) drug. The group of medicine effect includes hepatotonics, hepatotonics and anti-inflammatory drugs, antihistamine, respiratory apparatus drugs, circulatory system drug, digestives and stomachics drug, hormone and metabolic disease drugs, antibiotics and antimycotic, nutrientia and tonic, immunology, oncology, and the other drugs.